Now more than ever before, not only medical issues but also economic and social issues influence how health care is organized, governed, financed, and delivered.
Our empirical research advances understanding of the economics and regulation of the healthcare industry, with an emphasis on the biopharmaceutical and medical device industries. Faculty researchers examine a variety of issues, most typically around firm, industry, and regulatory organization and performance. Past and ongoing research includes the speed of drug development, sales and promotion strategies during adverse regulatory events, regulatory compliance, healthcare payment reform, and the effect of eHealth on health behaviors and outcomes. Some research projects entail the development and analysis of proprietary data, while others are conducted in collaboration with the U.S. Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC).
Principal Investigator and Convener: Jeffrey Macher
Coming Soon!
Catherine Tinsley comments on why the risk of contracting coronavirus is not enough to keep people apart in Fox News Feature
March 26th, 2020
Catherine Tinsley comments on why the risk of contracting coronavirus is not enough to keep people apart in Fox News Feature…
Robert Shapiro Calculates the Difficulty of Financing “Medicare for All” Programs
November 5th, 2019
Robert Shapiro Calculates the Difficulty of Financing “Medicare for All” Programs…
Macher and colleagues file amicus brief
December 21st, 2016
On December 21, Center for Business and Public Policy Academic Director Jeff Macher, along with eleven other signatories, submitted an amicus brief to the United States Court of…
